| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
L | | IP | | V/S | Infanrix DTPa-IPV | | 20.20 | 38.40 | 10 % | | 8 Active Agents | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | IP | | V/S | Engerix-B 20 | | 23.66 | 42.15 | 10 % | | Injection suspension: Hepatitidis b viri Antigenum Adnr 20 µg/ml | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Casgevy 4-13 x 10e6 cells/ml | | PR | PR | k.A. | | | Vertex Pharmaceuticals (CH) GmbH | A | FB | | G |  |
| | IP | CI | | Ebvallo | | PR | PR | k.A. | | | Pierre Fabre Pharma SA | A | FB | | G |  |
| | IP | CI | | BILAXIN Ophta 6 mg / ml | 5 ml | PR | PR | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | D | FB | | G |  |
| | IP | | V/S | Engerix-B 20 | 10 | PR | PR | k.A. | | Injection suspension: Hepatitidis b viri Antigenum Adnr 20 µg/ml | GlaxoSmithKline AG | B | FB | | G |  |
| | IP | CI | | Imodium ‐ I - T | 20 Capsule(s) | 3.87 | 6.85 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / SL / SO | FB | | G |  |
| | IP | CI | | Imodium - T | 60 Capsule(s) | 9.40 | 26.60 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | B / SL / SO | FB | | G |  |
| | IP | CI | | Incruse Ellipta | 30 unidose(s) | 34.64 | 54.10 | 10 % | | Inhalation Powder: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Incruse Ellipta | 3 x 30 unidose(s) | 103.00 | 128.45 | 10 % | | Inhalation Powder: Umeclidinium 62.5 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | IP | | V/S | Hiberix | Set(s) | 16.16 | 34.00 | 10 % | | Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | IP | CI | | Microlax | 4 x 5 ml | 4.15 | 7.65 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL | FB | | G |  |
L | | IP | CI | | Microlax | 12 x 5 ml | 12.45 | 23.00 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | IP | CI | | Microlax | 50 x 5 ml | 51.88 | 95.80 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | IP | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10 % | | Concentrate for infusion: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10 % | | Concentrate for infusion: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | CI | | D3 VitaCaps 24,000 IU (600 μg) | 6 | 7.65 | 17.55 | 10 % | | Soft capsules: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
L | | IP | CI | | Vitamin D3 Sandoz eco 1000 I.E. | 30 | 1.68 | 3.10 | 10 % | | Soft capsules: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | D / SL | FB | | G |  |
L | | IP | CI | | Vitamin D3 Sandoz eco 1000 I.E. | 90 | 5.04 | 9.30 | 10 % | | Soft capsules: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | D / SL | FB | | G |  |
L | | IP | CI | | Vitamin D3 Sandoz eco 3200 I.E. | 30 | 5.38 | 15.10 | 10 % | | Soft capsules: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | ● B / SL | FB | | G |  |
L | | IP | CI | | Vitamin D3 Sandoz eco 3200 I.E. | 90 | 16.13 | 33.95 | 10 % | | Soft capsules: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
L | | IP | CI | | Vitamin D3 Sandoz eco 25000 I.E. | 4 | 5.60 | 15.30 | 10 % | | Soft capsules: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | IP | CI | | Arnuity Ellipta 90 mcg | 30 unidose(s) | 15.60 | 33.40 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Arnuity Ellipta 90 mcg | 3 x 30 | 46.80 | 67.30 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Arnuity Ellipta 182 mcg | 30 unidose(s) | 25.58 | 44.25 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Arnuity Ellipta 182 mcg | 3 x 30 | 76.74 | 99.90 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | IP | | PP | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10 % | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | IP | | | Ogivri 150 mg | | 456.84 | 513.25 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G |  |
L | | IP | | V/S | Menveo | Kombipackung(en) | 31.69 | 50.90 | 10 % | | Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg Pulver und Lösung (Durchstechflaschen): 3 Active Agents | GlaxoSmithKline AG | B / SL | FB | | G |  |
L | | IP | | V/S | Menveo | 5 Kombipackung(en) | 158.45 | 37.75 | 10 % | | Pulver und Lösung (Durchstechflaschen): Oligosaccharida Neisseriae Meningitidis A 10 µg Pulver und Lösung (Durchstechflaschen): 3 Active Agents | GlaxoSmithKline AG | B / SL | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 10 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 12 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicorette Microtab Original-Aroma | 100 Tablet(s) | PR | PR | k.A. | | Sublingual tablets: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | D3 VitaCaps 24,000 IU (600 μg) | 4 | PR | PR | k.A. | | Soft capsules: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IP | CI | | D3 VitaCaps 24,000 IU (600 μg) | 8 | PR | PR | k.A. | | Soft capsules: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IP | CI | | D3 VitaCaps 24,000 IU (600 μg) | 12 | PR | PR | k.A. | | Soft capsules: Cholecalciferolum 600 µg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IP | CI | | Vitamin D3 Sandoz eco 25000 I.E. | 8 | PR | PR | k.A. | | Soft capsules: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | IP | CI | | Vitamin D3 Sandoz eco 25000 I.E. | 12 | PR | PR | k.A. | | Soft capsules: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | IP | | | Arnuity Ellipta 46 mcg | 30 | PR | PR | k.A. | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg | GlaxoSmithKline AG | B | FB | | G |  |
| | IP | CI | | Regaine 2 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 2 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | | | Mylotarg 5 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |
|
| | IP | CI | | Minirin 0,1 mg | 30 Tablet(s) | 19.36 | 37.35 | 10 % | | Tablets: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Minirin 0,1 mg | 90 Tablet(s) | 63.69 | 85.30 | 10 % | | Tablets: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Minirin 0,2 mg | 30 Tablet(s) | 34.50 | 53.70 | 10 % | | Tablets: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Minirin 0,2 mg | 90 Tablet(s) | 110.77 | 136.20 | 10 % | | Tablets: Desmopressini Acetas | Ferring AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Nocutil | 5 ml | 34.21 | 53.60 | 10 % | | Nasal spray: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Nocutil | 3 x 5 ml | 86.98 | 111.00 | 10 % | | Nasal spray: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Nocutil 0,1 mg | 30 Tablet(s) | 17.42 | 35.35 | 10 % | | Tablets: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Nocutil 0,1 mg | 90 Tablet(s) | 57.32 | 78.75 | 10 % | | Tablets: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Nocutil 0.2 mg | 30 Tablet(s) | 31.05 | 50.20 | 10 % | | Tablets: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Nocutil 0.2 mg | 90 Tablet(s) | 99.69 | 124.85 | 10 % | | Tablets: Desmopressini Acetas | Gebro Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Octostim 15 ug | 10 1 ampoule(s) à 1 ml | 257.92 | 296.90 | 10 % | | Infusion solution: Desmopressini Acetas 15 µg/ml | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Minirin Melt 60 µg | 30 Tablet(s) | 19.36 | 37.45 | 10 % | | Sublingual tablets: Desmopressinum 60 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Minirin Melt 60 µg | 100 Tablet(s) | 70.76 | 93.35 | 10 % | | Sublingual tablets: Desmopressinum 60 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Minirin Melt 120 µg | 30 Tablet(s) | 34.50 | 53.95 | 10 % | | Sublingual tablets: Desmopressinum 120 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Minirin Melt 120 µg | 100 Tablet(s) | 123.07 | 150.25 | 10 % | | Sublingual tablets: Desmopressinum 120 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | | | Minirin | 10 1 ampoule(s) à 4 ug | PR | PR | k.A. | | Injection solution: Desmopressini Acetas 4 µg/ml | Ferring AG | B | FB | | G |  |
| | IP | CI | | Minirin | 6 ml | 38.66 | 60.80 | k.A. | | Nasal spray: Desmopressini Acetas | Ferring AG | B | FB | | G |  |
| | IP | CI | | Octostim | 2.5 ml | PR | PR | k.A. | | Nasal spray: Desmopressini Acetas 1.5 mg/ml | Ferring AG | B | FB | | G |  |